WELCOME TO THE ITOC6
THE 6TH LEADING INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE IN EUROPE
The Cancer Drug Development Forum (CDDF) and the Society for Immunotherapy of Cancer (SITC) have the great pleasure to invite you to take part in the 6th Immunotherapy of Cancer Conference (ITOC6) – the leading European conference providing a global platform for translational research in the field of immuno-oncology.
The ITOC series of conferences is the premier meeting for education, scientific exchange and networking within cancer immunotherapy.
The sixth edition (ITOC6) will take place in Vienna, Austria from April 11 – 13, 2019.
It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research.
The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development.
At this conference, we are in particular addressing preclinical and clinical scientists, clinical investigators, postdoctoral fellows involved in cancer research, regulatory scientists, healthcare professionals and the pharmaceutical industry.
Help us promoting the conference: Congress Flyer for download
Print it out and pin it to your notice board!
Start of Online Registration: Monday, September 1, 2018
Start of Abstract Submission: Monday, September 1, 2018
Deadline for Abstract Submission: Monday, December 17, 2018
Deadline for Registration at the Reduced Registration Fee: Monday, December 17, 2018
Deadline for Online Registration: Monday, April 1, 2019
- About Vienna
- Abstract Submission
- CME Credits & Compliance
- Data Protection Policy
- General Information from A to Z
- General Terms & Conditions
- Guidelines for Presenters
- Networking Events
- Scientific Committee
- Scientific Programme
This is an ESO recommended event.
Join the discussion on Twitter by using #ITOC6 !